Clinigen Group (CLIN)
29/12/2017 - 09:00 RNS
RNS Number: 9389Z Clinigen Group plc 29 December 2017 29 December 2017 Clinigen Group plc ("Clinigen" or the "Group") Total Voting Rights and Capital In conformity with Rule 5.6.1 of the Disclosure Guidance and Transparency Rules, the Group notifies the market that as at 29 December 2017 Clinigen's issued share capital consists of 122,286,083 ordinary shares...
06/12/2017 - 07:48 StockMarketWire
Clinigen Group director Chris Rigg has resigned with immediate effect to seek a chief executive role elsewhere. Clinigen CE...
06/12/2017 - 07:00 RNS
RNS Number: 4871Y Clinigen Group plc 06 December 2017 6 December 2017 Directorate Change Clinigen Group plc (AIM: CLIN, 'Clinigen' or the 'Group'), the global pharmaceutical and services company, announces that Chris Rigg has resigned with immediate effect as a director to seek a CEO role elsewhere. Shaun Chilton, CEO of Clinigen, said: "On behalf of the B...
05/12/2017 - 08:29 StockMarketWire
Clinigen Group issued 17,925 ordinary shares yesterday to satisfy share options vesting under the group's all staff long term...
Join interactive investor
- £22.50 fixed quarterly charge includes £22.50 in trading credits
- £10 per trade or £6 for frequent traders
- No % platform fees
- £1 per trade for regular investment or dividend reinvestment